[1]. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2.
Esophagus : official journal of the Japan Esophageal Society （2023年） [査読] 有
[DOI] [2]. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.
Esophagus : official journal of the Japan Esophageal Society [頁]1 -30 （2023年） [査読] 有
[DOI] [3]. Recent Advances in Sentinel Node Navigation Surgery for Early Gastric Cancer.
Journal of gastric cancer [巻]23 [号]1 [頁]159 -170 （2023年） [査読] 有
[DOI] [4]. How to improve the prognosis of high-risk elderly gastric cancer patients.
Annals of gastroenterological surgery [巻]6 [号]6 [頁]736 -737 （2022年） [査読] 有
[DOI] [5]. ロボット支援下胸部食道切除術の術後短期成績の検討
外科と代謝・栄養 日本外科代謝栄養学会 [巻]56 [号]5 [頁]196 -201 （2022年） [査読] 有
[DOI] [6]. 【食道疾患の診療】食道癌の診療 「食道癌診療ガイドライン」の概要
臨床消化器内科 (株)日本メディカルセンター [巻]37 [号]9 [頁]1048 -1054 （2022年） [査読] 有
[DOI] [7]. Usefulness of Procalcitonin as a Predictor of Long-Term Prognosis in the Early Postoperative Period after Esophagectomy for Esophageal Cancer.
Journal of clinical medicine [巻]11 [号]12 （2022年） [査読] 有
[DOI] [8]. Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer.
Anticancer research [巻]42 [号]6 [頁]2977 -2987 （2022年） [査読] 有
[DOI] [9]. Endoscopic imaging modalities for diagnosing the invasion depth of superficial esophageal squamous cell carcinoma: a systematic review.
Esophagus （2022年） [査読] 有
[DOI] [10]. Usefulness of wearable fitness tracking devices in patients undergoing esophagectomy.
Esophagus [巻]19 [号]2 [頁]260 -268 （2022年） [査読] 有
[DOI] [11]. Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.
Gastric cancer （2022年） [査読] 有
[DOI] [12]. Optimal neoadjuvant chemotherapy for resectable advanced gastric cancer
Digestive Medicine Research （2022年） [査読] 有
[13]. ASO Visual Abstract: Development and Validation of the Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer: A Multicenter Retrospective Study.
Annals of surgical oncology （2022年） [査読] 有
[DOI] [14]. Development and Validation of the Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer: A Multicenter, Retrospective Study.
Annals of surgical oncology （2022年） [査読] 有
[DOI] [機関リポジトリ][15]. The potential for reducing alcohol consumption to prevent esophageal cancer morbidity in Asian heavy drinkers: a systematic review and meta-analysis.
Esophagus [巻]19 [号]1 [頁]39 -46 （2022年） [査読] 有
[DOI] [16]. Fruit and vegetable consumption and risk of esophageal cancer in the Asian region: a systematic review and meta-analysis.
Esophagus [巻]19 [号]1 [頁]27 -38 （2022年） [査読] 有
[DOI] [17]. Nationwide survey of the follow-up practices for patients with esophageal carcinoma after radical treatment: historical changes and future perspectives in Japan.
Esophagus [巻]19 [号]1 [頁]69 -76 （2022年） [査読] 有
[DOI] [18]. 【見直される上部消化管癌の治療戦略】総論 食道癌診療ガイドラインにみる治療戦略の展望
外科 (株)南江堂 [巻]84 [号]1 [頁]1 -6 （2022年）
[DOI] [19]. 高度肥満症に対する腹腔鏡下スリーブ状胃切除術の短期・長期成績の検討
日本内視鏡外科学会雑誌 (一社)日本内視鏡外科学会 [巻]26 [号]7 [頁]MO240 -3 （2021年）
[20]. The Impact of Infectious Complications after Esophagectomy for Esophageal Cancer on Cancer Prognosis and Treatment Strategy.
Journal of clinical medicine [巻]10 [号]19 （2021年） [査読] 有
[DOI] [21]. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Esophagus [巻]18 [号]4 [頁]743 -752 （2021年） [査読] 有
[DOI] [22]. Short-term Outcomes of Robot-assisted Minimally Invasive Esophagectomy Compared With Thoracoscopic or Transthoracic Esophagectomy.
Anticancer research [巻]41 [号]9 [頁]4455 -4462 （2021年） [査読] 有
[DOI] [23]. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
World journal of surgery [巻]45 [号]6 [頁]1835 -1844 （2021年） [査読] 有
[DOI] [機関リポジトリ][24]. The Negative Impact of Preoperative Chemotherapy on Survival After Esophagectomy for Vulnerable Elderly Patients with Esophageal Cancer.
Annals of surgical oncology [巻]28 [号]3 [頁]1786 -1795 （2021年） [査読] 有
[DOI] [25]. ASO Author Reflections: The Impact of Preoperative Chemotherapy on Survival After Esophagectomy in Elderly Patients with Esophageal Cancer.
Annals of surgical oncology [巻]28 [号]3 [頁]1796 -1797 （2021年） [査読] 有
[DOI] [26]. Utility of the evaluation of blood flow of remnant esophagus with indocyanine green in esophagectomy with jejunum reconstruction: Case series.
Annals of medicine and surgery (2012) [巻]62 [頁]21 -25 （2021年） [査読] 有
[DOI] [27]. Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.
Cancer science [巻]112 [号]2 [頁]751 -759 （2021年） [査読] 有
[DOI] [28]. Impact of Immune-related Adverse Events on Nivolumab Efficacy in Patients With Upper Gastrointestinal Cancer.
In vivo [巻]35 [号]4 [頁]2321 -2326 （2021年） [査読] 有
[DOI] [29]. Postoperative chylothorax with a duplicated left-sided thoracic duct: a case report and review of the literature.
General thoracic and cardiovascular surgery [巻]68 [号]11 [頁]1350 -1353 （2020年） [査読] 有
[DOI] [機関リポジトリ][30]. Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.
Annals of surgical oncology [巻]27 [号]9 [頁]3163 -3170 （2020年） [査読] 有
[DOI] [31]. ASO Author Reflections: Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.
Annals of surgical oncology [巻]27 [号]9 [頁]3171 -3172 （2020年） [査読] 有
[DOI] [32]. The impact of epidural catheter insertion level on pain control after esophagectomy for esophageal cancer.
Esophagus [巻]17 [号]2 [頁]175 -182 （2020年） [査読] 有
[DOI] [33]. Ability of Laparoscopic Gastric Mobilization to Prevent Pulmonary Complications After Open Thoracotomy or Thoracoscopic Esophagectomy for Esophageal Cancer: A Systematic Review and Meta-analysis.
World journal of surgery [巻]44 [号]3 [頁]980 -989 （2020年） [査読] 有
[DOI] [34]. A Case of Giant Hematogenous Left Quadricep Muscle Metastasis of Hepatocellular Carcinoma.
Gan to kagaku ryoho. Cancer & chemotherapy [巻]46 [号]5 [頁]925 -928 （2019年） [査読] 有
[35]. Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment.
World journal of surgery [巻]43 [号]5 [頁]1286 -1293 （2019年） [査読] 有
[DOI] [36]. Laparoscopic completion gastrectomy in elderly patients with remnant gastric cancer: a case series.
Surgical case reports [巻]5 [号]1 [頁]63 （2019年） [査読] 有
[DOI] [37]. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.
Esophagus [巻]16 [号]1 [頁]25 -43 （2019年） [査読] 有
[DOI] [38]. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.
Esophagus [巻]16 [号]1 [頁]1 -24 （2019年） [査読] 有
[DOI] [39]. Recent advances in thoracoscopic esophagectomy for esophageal cancer.
Asian journal of endoscopic surgery [巻]12 [号]1 [頁]19 -29 （2019年） [査読] 有
[DOI] [40]. Laparoscopic total gastrectomy for remnant gastric cancer: A single-institution experience.
Asian journal of endoscopic surgery [巻]12 [号]1 [頁]58 -63 （2019年） [査読] 有
[DOI] [41]. Life-threatening giant esophageal neurofibroma with severe tracheal stenosis: a case report.
Surgical case reports [巻]4 [号]1 [頁]107 （2018年） [査読] 有
[DOI] [42]. Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancer.
BJS open [巻]2 [号]5 [頁]276 -284 （2018年） [査読] 有
[DOI] [43]. Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.
Oncology letters [巻]16 [号]1 [頁]1348 -1356 （2018年） [査読] 有
[DOI] [44]. Reply to: Preventive role of ramelteon and suvorexant for postoperative delirium after pharyngolaryngectomy with esophagectomy.
Esophagus [巻]15 [号]3 [頁]207 （2018年） [査読] 有
[DOI] [45]. Perioperative Risk Calculator Predicts Long-Term Oncologic Outcome for Patients with Esophageal Carcinoma.
Annals of surgical oncology [巻]25 [号]3 [頁]837 -843 （2018年） [査読] 有
[DOI] [46]. Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal Cancer.
Annals of surgical oncology [巻]24 [号]3 [頁]778 -784 （2017年） [査読] 有
[DOI] [47]. Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant.
Esophagus [巻]14 [号]3 [頁]229 -234 （2017年） [査読] 有
[DOI] [48]. Incidence and risk factors for postoperative delirium after major head and neck cancer surgery.
Journal of cranio-maxillo-facial surgery [巻]44 [号]7 [頁]890 -4 （2016年） [査読] 有
[DOI] [49]. Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study.
Gastric cancer [巻]19 [号]3 [頁]876 -86 （2016年） [査読] 有
[DOI] [50]. Risk factors for complications after pharyngolaryngectomy with total esophagectomy.
Esophagus [巻]13 [号]4 [頁]317 -322 （2016年） [査読] 有
[DOI] [51]. The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer.
Medicine [巻]94 [号]33 [頁]e1369 （2015年） [査読] 有
[DOI] [52]. Superior Mesenteric Artery Syndrome Caused by Massive Lumbar Osteophytes: A Case Report.
Spine [巻]40 [号]15 [頁]E909 -12 （2015年） [査読] 有
[DOI] [53]. Gastric tube cancer after radical esophagectomy: comparison of two periods in a single center
Esophagus （2015年） [査読] 有
[54]. A case of late lymph node metastasis after three endoscopic mucosal resections of intramucosal gastric cancers.
World journal of surgical oncology [巻]12 [頁]339 （2014年） [査読] 有
[DOI]